Psychiatry and Neurology, Neurology · Houston, TX
NPI
1164423588
Since 2005
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
6624 Fannin St, Suite 1670
Houston, TX, 77030
Phone (713) 795-0033
Groups this clinician bills Medicare through
Medicare paid, 2024
$442K
9,804 services
Medicare patients, 2024
223
Average age 73
Drug cost, 2024
$1.7M
870 prescriptions
Company payments, 2025
$146
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Aziz Shaibani was code 99214 (office e&m - established), 183 times for 116 patients. In total Aziz Shaibani billed 9,804 services in 34 codes, and Medicare paid $442K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-11-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 183 | 116 | $99.19 | $18K |
| 95886 Electrical Nerve Conductivity | Office | 161 | 89 | $77.61 | $12K |
| 88319 Surgical Pathology Examination | Office | 128 | 12 | $110.15 | $14K |
| 99204 Office E&M - New | Office | 98 | 98 | $132.42 | $13K |
| 88342 Immunohistochemistry | Office | 66 | 18 | $85.59 | $5,649 |
| 88314 Surgical Pathology Examination | Office | 66 | 11 | $71.59 | $4,725 |
| 88305 Surgical Pathology Examination | Office | 54 | 19 | $58.03 | $3,134 |
| 95910 Electrical Nerve Conductivity | Office | 40 | 40 | $140.57 | $5,623 |
| 99203 Office E&M - New | Office | 32 | 32 | $85.54 | $2,737 |
| 95923 Electrical Nerve Conductivity | Office | 27 | 27 | $92.40 | $2,495 |
| 95924 Electrical Nerve Conductivity | Office | 27 | 27 | $119.32 | $3,222 |
| 95909 Electrical Nerve Conductivity | Office | 20 | 20 | $108.83 | $2,177 |
| 99213 Office E&M - Established | Office | 20 | 17 | $60.74 | $1,215 |
| 99215 Office E&M - Established | Office | 16 | 16 | $120.30 | $1,925 |
| 95908 Electrical Nerve Conductivity | Office | 14 | 14 | $90.69 | $1,270 |
By year: 2022 $383K for 6,605 services; 2023 $407K for 8,445 services; 2024 $442K for 9,804 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88319 Surgical Pathology Examination | 128 | 12 | $110.15 | $14K |
| 88314 Surgical Pathology Examination | 66 | 11 | $71.59 | $4,725 |
| 88342 Immunohistochemistry | 66 | 18 | $85.59 | $5,649 |
| 88305 Surgical Pathology Examination | 54 | 19 | $58.03 | $3,134 |
Medicare prescription drug claims, 2024
In 2024, the drug Aziz Shaibani prescribed most often to Medicare patients was Prednisone, with 182 prescriptions and refills. In total Aziz Shaibani wrote 870 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 182 | 510 | 69 | $2,160 |
| Azathioprine Generic | 181 | 332 | 37 | $16K |
| Pyridostigmine Bromide Generic | 116 | 161 | 32 | $6,550 |
| Riluzole Generic | 79 | 180 | 30 | $19K |
| Nortriptyline Hcl Generic | 32 | 44 | Under 11 | $260 |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 30 | 30 | Under 11 | $184K |
| Privigen Immun Glob G(Igg)/Pro/Iga 0-50 | 29 | 29 | Under 11 | $412K |
| Mycophenolate Mofetil Generic | 22 | 34 | Under 11 | $4,226 |
| Sodium Chloride 0.9 % Sodium Chloride | 14 | 14 | Under 11 | $222 |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 14 | 14 | Under 11 | $230K |
| Gabapentin Generic | 13 | 21 | Under 11 | $269 |
| Gammaked Immune Globul G/Gly/Iga Avg 46 | 12 | 12 | Under 11 | $138K |
Brand drugs: 137 claims; generic drugs: 733 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Aziz Shaibani $146 ($146 in general payments such as food, travel and fees) from 11 companies. The largest payer was UCB, Inc. with $65.75.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.